Impacts of Overweight and Obesity in Older Age on the Risk of Dementia: A Systematic Literature Review and a Meta-Analysis.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2019
Historique:
pubmed: 29 1 2019
medline: 21 10 2020
entrez: 29 1 2019
Statut: ppublish

Résumé

It is unclear whether overweight and obesity in older age reduces or increases the risk of incident dementia. To assess the impacts of overweight and obesity in older age on incident dementia. We searched cohort studies reporting body weight measured in older age and dementia through PubMed, Embase, Medline, PyschInfo, and Cochrane library until July 2016. Sixteen articles were identified for the review. We pooled data from them and a new unpublished study from China, to calculate relative risk (RR) of incident dementia in relation to body mass index (BMI) and waist circumference (WC). All 16 cohort studies were undertaken in high income countries, with follow-up periods ranging between 3 to 18 years. Thirteen studies showed an inverse association between BMI and dementia, and three studies demonstrated a positive association. Pooled RR of dementia in relation to continuous BMI from 14 studied populations, including the new Chinese data, was 0.97 (95% CI 0.95-1.00); in those followed up <9 years it was 0.95 (0.93-0.96) while in ≥9 years follow-up it was 1.03 (0.96-1.11). In five studied populations examining categorical BMI, RR of dementia in older people classified as overweight and obese was 0.98 (0.54-1.77) and 1.17 (0.65-2.10) respectively, in comparison with other weights. The pooled WC data showed no association between increased WC and reduced risk of dementia. The current evidence did not support a paradox on beneficial impacts of overweight and obesity in older age on incident dementia. More studies with long term follow up are needed to clarify the association of body weight in older age with dementia risk.

Sections du résumé

BACKGROUND
It is unclear whether overweight and obesity in older age reduces or increases the risk of incident dementia.
OBJECTIVE
To assess the impacts of overweight and obesity in older age on incident dementia.
METHODS
We searched cohort studies reporting body weight measured in older age and dementia through PubMed, Embase, Medline, PyschInfo, and Cochrane library until July 2016. Sixteen articles were identified for the review. We pooled data from them and a new unpublished study from China, to calculate relative risk (RR) of incident dementia in relation to body mass index (BMI) and waist circumference (WC).
RESULTS
All 16 cohort studies were undertaken in high income countries, with follow-up periods ranging between 3 to 18 years. Thirteen studies showed an inverse association between BMI and dementia, and three studies demonstrated a positive association. Pooled RR of dementia in relation to continuous BMI from 14 studied populations, including the new Chinese data, was 0.97 (95% CI 0.95-1.00); in those followed up <9 years it was 0.95 (0.93-0.96) while in ≥9 years follow-up it was 1.03 (0.96-1.11). In five studied populations examining categorical BMI, RR of dementia in older people classified as overweight and obese was 0.98 (0.54-1.77) and 1.17 (0.65-2.10) respectively, in comparison with other weights. The pooled WC data showed no association between increased WC and reduced risk of dementia.
CONCLUSION
The current evidence did not support a paradox on beneficial impacts of overweight and obesity in older age on incident dementia. More studies with long term follow up are needed to clarify the association of body weight in older age with dementia risk.

Identifiants

pubmed: 30689574
pii: JAD180763
doi: 10.3233/JAD-180763
pmc: PMC6700617
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S87-S99

Références

Neurology. 2001 Oct 23;57(8):1453-60
pubmed: 11673588
Int J Obes Relat Metab Disord. 2001 Nov;25(11):1730-5
pubmed: 11753597
Neurology. 2003 Jan 14;60(1):117-9
pubmed: 12525731
J R Soc Med. 2003 Mar;96(3):118-21
pubmed: 12612111
Arch Intern Med. 2003 Jul 14;163(13):1524-8
pubmed: 12860573
Int J Obes (Lond). 2005 Sep;29(9):1011-29
pubmed: 15925957
Neurology. 2005 Sep 27;65(6):892-7
pubmed: 16186530
Lancet Neurol. 2006 Jan;5(1):64-74
pubmed: 16361024
Alzheimer Dis Assoc Disord. 2006 Apr-Jun;20(2):93-100
pubmed: 16772744
Arch Neurol. 2006 Sep;63(9):1312-7
pubmed: 16966511
Neurology. 2006 Dec 12;67(11):1949-54
pubmed: 17159099
Arch Neurol. 2007 Mar;64(3):392-8
pubmed: 17353383
Eur Heart J. 2007 Apr;28(7):850-6
pubmed: 17403720
Am J Epidemiol. 2007 Aug 15;166(4):367-78
pubmed: 17573335
Neurology. 2007 Aug 21;69(8):739-46
pubmed: 17709705
J Am Geriatr Soc. 2008 Jan;56(1):111-6
pubmed: 18028342
Obes Rev. 2008 May;9(3):204-18
pubmed: 18331422
Circulation. 2008 Apr 1;117(13):1658-67
pubmed: 18362231
J Am Geriatr Soc. 2008 Dec;56(12):2261-6
pubmed: 19093925
Arch Neurol. 2009 Mar;66(3):336-42
pubmed: 19273752
J Alzheimers Dis. 2009;16(4):693-704
pubmed: 19387106
Neurology. 2009 May 19;72(20):1741-6
pubmed: 19451529
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
JAMA. 2009 Aug 12;302(6):627-37
pubmed: 19671904
Neurology. 2009 Nov 10;73(19):1559-66
pubmed: 19901247
Am J Epidemiol. 2011 Jan 1;173(1):1-9
pubmed: 21059807
Obes Rev. 2011 May;12(5):e426-37
pubmed: 21348917
PLoS One. 2011 Mar 25;6(3):e17902
pubmed: 21464984
J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1149-56
pubmed: 21493755
J Stroke Cerebrovasc Dis. 2013 Feb;22(2):119-25
pubmed: 21835633
J Alzheimers Dis. 2012;30 Suppl 2:S97-112
pubmed: 22543853
J Alzheimers Dis. 2014;38(1):201-9
pubmed: 23948937
Eur Neuropsychopharmacol. 2014 Jul;24(7):1056-66
pubmed: 24721317
J Diabetes Investig. 2013 Nov 27;4(6):640-50
pubmed: 24843720
Postgrad Med J. 2014 Oct;90(1068):547-51
pubmed: 25143590
J Alzheimers Dis. 2015;43(3):739-55
pubmed: 25147111
Alzheimers Dement. 2015 Mar;11(3):258-70.e3
pubmed: 25150732
Front Neurosci. 2014 Nov 19;8:375
pubmed: 25477778
Lancet Diabetes Endocrinol. 2015 Jun;3(6):431-436
pubmed: 25866264
Age Ageing. 2016 Jan;45(1):14-21
pubmed: 26764391
Medicine (Baltimore). 2016 Jan;95(2):e2424
pubmed: 26765423
Age (Dordr). 2016 Feb;38(1):23
pubmed: 26846415
Medicine (Baltimore). 2016 Mar;95(11):e3112
pubmed: 26986157
Alzheimers Dement. 2016 Apr;12(4):459-509
pubmed: 27570871
Ann Med. 2017 Sep;49(6):462-469
pubmed: 28151011
Alzheimers Dement (Amst). 2017 Jun 20;8:165-178
pubmed: 28761927
Alzheimers Dement. 2018 May;14(5):601-609
pubmed: 29169013
Neurology. 2018 Jul 31;91(5):e427-e435
pubmed: 29997193
Neurology. 1995 Jun;45(6):1161-8
pubmed: 7783883

Auteurs

Isaac M Danat (IM)

Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK.

Angela Clifford (A)

Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK.

Martin Partridge (M)

Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK.

Weiju Zhou (W)

Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK.

Aishat T Bakre (AT)

Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK.

Anthony Chen (A)

Faculty of Sciences and Technology, Middlesex University, London, UK.

Danielle McFeeters (D)

Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK.

Tina Smith (T)

Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK.

Yuhui Wan (Y)

School of Public Health, Anhui Medical University, Hefei, Anhui, China.

John Copeland (J)

Institute of Psychology, Health and Society, University of Liverpool, Liverpool, UK.

Kaarin J Anstey (KJ)

School of Psychology, University of New South Wales and Neuroscience Research Australia, Sydney, Australia.

Ruoling Chen (R)

Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH